Dr. Lakshmana K. Pendyala, MD

Dr. Pendyala practices at Baptist Health Floyd in New Albany, Indiana, part of Baptist Health.

Dr. Pendyala's NPI, 1144217746, was assigned on September 29, 2005. Dr. Pendyala holds Indiana license 01066037A.

Dr. Pendyala's primary practice is Baptist Health Floyd, at 1850 State St, New Albany, IN 47150 in Floyd County. The practice phone is (812) 944-7701.

Dr. Pendyala's primary practice is Baptist Health Floyd in New Albany, Indiana, part of Baptist Health. Dr. Pendyala is also affiliated with Norton Clark Hospital. The medical group on file is Baptist Health Medical Group. Dmand AI also links Dr. Pendyala to 3 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Pendyala practices, 6 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Pendyala's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dmand AI has Dr. Pendyala's licenses on file in 2 states: Indiana and Kentucky.

CMS data shows 4,559 Medicare services from Dr. Pendyala across 25 procedure codes in 2024, for 1,343 Medicare patients. Medicare paid $194,973 for them.

CMS counts 1,343 Medicare patients who saw Dr. Pendyala in 2024. The largest group is 65 to 74, with 553 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 15% are also on Medicaid. Their average risk score is 1.71, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Pendyala's median patient age at 66, with 52% women.

In 2024, Dr. Pendyala wrote 6,978 Medicare Part D claims for 807 patients. 86% of them were for generic drugs. CMS names the drug for 6,689 of them, across 58 drugs with 11 or more claims each, at $870,874 in total drug cost. In 2023, CMS named 7,016 claims across 60 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Pendyala for performance year 2024, reported through an alternative payment model (APM). Dr. Pendyala accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Coronary angioplasty and stenting: 1 to 10 procedures (CMS shows small counts as a range)

Pacemaker insertion or repair: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 38 papers to Dr. Pendyala, published from 2011 to 2016. 2014 was the busiest year, with 14. The most frequent topics are Percutaneous Coronary Intervention, Drug-Eluting Stents and Myocardial Infarction. Dr. Pendyala has published most often in Am J Cardiol. Dr. Pendyala's most frequent co-authors are Ron Waksman, MD, Lowell Franklin Satler, MD and William O. Suddath, MD.

CMS Open Payments shows 728 general payments to Dr. Pendyala from 54 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 60% of the total. AstraZeneca Pharmaceuticals LP paid the most, $35,244.